Zevra Therapeutics, Inc. (ZVRA) Gross margin 2019–2023
Zevra Therapeutics, Inc. (ZVRA) gross margin by fiscal year — reported gross profit divided by reported revenue.
89.3%FY2023 · since FY2019: 22.1% → 89.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | 89.3% | -8.5 pp |
| FY2022 | 97.8% | +5.0 pp |
| FY2021 | 92.8% | — |
| FY2019 | 22.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ZVRA financial trends
ZVRA RevenueZVRA Net incomeZVRA Net marginZVRA Gross profitZVRA Operating incomeZVRA Operating marginZVRA Operating cash flowZVRA Free cash flowZVRA Capital expendituresZVRA Return on equityZVRA Stock buybacksZVRA Dividends paidZVRA Total assetsZVRA Total liabilitiesZVRA Shareholders’ equityZVRA overview →